Flupenthixol Decanoate in Methamphetamine Smoking – 1
Overview
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
Full Title of Study: “Flupenthixol Decanoate in Methamphetamine Smoking”
Study Type
- Study Type: Interventional
- Study Design
- Primary Purpose: Treatment
Interventions
- Drug: Flupenthixol
Clinical Trial Outcome Measures
Primary Measures
- Methamphetamine use
Participating in This Clinical Trial
Please contact site for information.
Gender Eligibility: All
Minimum Age: 22 Years
Maximum Age: 45 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Collaborator
- Friends Research Institute, Inc.
- Overall Official(s)
- Frank Gawin, M.D., Principal Investigator, Friends Research Institute, Inc.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.